| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 02:41:35 UTC |
|---|
| Update Date | 2022-11-30 19:25:54 UTC |
|---|
| HMDB ID | HMDB0114781 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(14:0/18:3(9Z,12Z,15Z)) |
|---|
| Description | PA(14:0/18:3(9Z,12Z,15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of alpha-linolenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC InChI=1S/C35H63O8P/c1-3-5-7-9-11-13-15-16-17-18-20-22-24-26-28-30-35(37)43-33(32-42-44(38,39)40)31-41-34(36)29-27-25-23-21-19-14-12-10-8-6-4-2/h5,7,11,13,16-17,33H,3-4,6,8-10,12,14-15,18-32H2,1-2H3,(H2,38,39,40)/b7-5-,13-11-,17-16-/t33-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Myristoyl-2-alpha-linolenoyl-sn-glycero-3-phosphate | HMDB | | 1-Myristoyl-2-alpha-linolenoyl-sn-phosphatidic acid | HMDB | | PA(14:0/18:3) | HMDB | | PA(14:0/18:3N3) | HMDB | | PA(14:0/18:3W3) | HMDB | | PA(32:3) | HMDB | | Phosphatidic acid(14:0/18:3(9Z,12Z,15Z)) | HMDB | | Phosphatidic acid(14:0/18:3) | HMDB | | Phosphatidic acid(14:0/18:3n3) | HMDB | | Phosphatidic acid(14:0/18:3W3) | HMDB | | Phosphatidic acid(32:3) | HMDB | | Phosphatidate(14:0/18:3(9Z,12Z,15Z)) | HMDB | | Phosphatidate(14:0/18:3) | HMDB | | Phosphatidate(14:0/18:3N3) | HMDB | | Phosphatidate(14:0/18:3W3) | HMDB | | Phosphatidate(32:3) | HMDB | | 1-myristoyl-2-alpha-linolenoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-myristoyl-2-alpha-linolenoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(14:0/18:3) | SMPDB, HMDB | | PA(14:0/18:3n3) | SMPDB, HMDB | | PA(14:0/18:3w3) | SMPDB, HMDB | | PA(32:3) | SMPDB, HMDB | | Phosphatidic acid(14:0/18:3(9Z,12Z,15Z)) | SMPDB, HMDB | | Phosphatidic acid(14:0/18:3) | SMPDB, HMDB | | Phosphatidic acid(14:0/18:3n3) | SMPDB, HMDB | | Phosphatidic acid(14:0/18:3w3) | SMPDB, HMDB | | Phosphatidic acid(32:3) | SMPDB, HMDB | | Phosphatidate(14:0/18:3(9Z,12Z,15Z)) | SMPDB, HMDB | | Phosphatidate(14:0/18:3) | SMPDB, HMDB | | Phosphatidate(14:0/18:3n3) | SMPDB, HMDB | | Phosphatidate(14:0/18:3w3) | SMPDB, HMDB | | PA(14:0/18:3(9Z,12Z,15Z)) | SMPDB |
|
|---|
| Chemical Formula | C35H63O8P |
|---|
| Average Molecular Weight | 642.855 |
|---|
| Monoisotopic Molecular Weight | 642.426055987 |
|---|
| IUPAC Name | [(2R)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]-3-(tetradecanoyloxy)propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]-3-(tetradecanoyloxy)propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC |
|---|
| InChI Identifier | InChI=1S/C35H63O8P/c1-3-5-7-9-11-13-15-16-17-18-20-22-24-26-28-30-35(37)43-33(32-42-44(38,39)40)31-41-34(36)29-27-25-23-21-19-14-12-10-8-6-4-2/h5,7,11,13,16-17,33H,3-4,6,8-10,12,14-15,18-32H2,1-2H3,(H2,38,39,40)/b7-5-,13-11-,17-16-/t33-/m1/s1 |
|---|
| InChI Key | PWUDKZCTVRNPPI-DKEKZCSRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0064148)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0064153)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0064155)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/22:2(13Z,16Z)) (PathBank: SMP0064158)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0064159)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0072897)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0072898)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0072903)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0072905)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/22:1(13Z)) (PathBank: SMP0072908)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0072912)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0096897)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0096912)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0064151)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/22:0) (PathBank: SMP0064156)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0064162)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/24:1(15Z)) (PathBank: SMP0064164)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0088174)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0096894)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0096904)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0096913)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/20:1(11Z)) (PathBank: SMP0064149)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/20:2(11Z,14Z)) (PathBank: SMP0064150)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/24:0) (PathBank: SMP0072914)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/20:0) (PathBank: SMP0096901)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0096903)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0096916)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0096895)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0096898)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/14:0) (PathBank: SMP0016761)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/15:0) (PathBank: SMP0016762)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/16:0) (PathBank: SMP0016763)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/18:0) (PathBank: SMP0016764)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/14:1(9Z)) (PathBank: SMP0016768)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/16:1(9Z)) (PathBank: SMP0016769)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/18:1(11Z)) (PathBank: SMP0016770)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/18:1(9Z)) (PathBank: SMP0016771)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/18:2(9Z,12Z)) (PathBank: SMP0016776)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0016777)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083273)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083274)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083277)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0083279)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0083280)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083283)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083284)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083285)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083286)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083287)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083288)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083289)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083290)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083291)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083292)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083296)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083299)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083300)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:1(11Z)) (PathBank: SMP0096896)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:0) (PathBank: SMP0096899)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:1(13Z)) (PathBank: SMP0096900)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/20:1(11Z)) (PathBank: SMP0096902)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/22:0) (PathBank: SMP0096905)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:0/22:1(13Z)) (PathBank: SMP0096906)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:1(11Z)/20:1(11Z)) (PathBank: SMP0096907)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0096908)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0096909)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:1(11Z)/22:0) (PathBank: SMP0096910)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:1(11Z)/22:1(13Z)) (PathBank: SMP0096911)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0096914)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0096915)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0096917)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0096918)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/22:0/22:0) (PathBank: SMP0096919)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/22:0/22:1(13Z)) (PathBank: SMP0096920)
- Cardiolipin Biosynthesis CL(14:0/18:3(9Z,12Z,15Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0096921)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 8.68 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 29.2992 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.97 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4524.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 368.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 296.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 217.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 964.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1545.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1116.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 218.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2978.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1007.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2469.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1131.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 637.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 414.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 669.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(14:0/18:3(9Z,12Z,15Z)),1TMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4534.8 | Semi standard non polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),1TMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4064.0 | Standard non polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),1TMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 5382.5 | Standard polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),2TMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4511.4 | Semi standard non polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),2TMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4044.1 | Standard non polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),2TMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4692.5 | Standard polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),1TBDMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4756.4 | Semi standard non polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),1TBDMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4173.8 | Standard non polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),1TBDMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5369.4 | Standard polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),2TBDMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4961.8 | Semi standard non polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),2TBDMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4222.4 | Standard non polar | 33892256 | | PA(14:0/18:3(9Z,12Z,15Z)),2TBDMS,isomer #1 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4748.5 | Standard polar | 33892256 |
|
|---|